TETERBORO, N.J., May 7, 2002 /PRNewswire-FirstCall via COMTEX/ -- Quest
Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of
diagnostic testing, information and services, announced that Kenneth R.
Finnegan, Vice President Business Development, is scheduled to speak at the
Deutsche Bank Securities 27th Annual Health Care Conference on Wednesday, May 8,
2002, at the Baltimore Marriott Waterfront, Baltimore, Maryland. The Quest
Diagnostics presentation is scheduled to begin at 2:00 p.m. Eastern Time.
The conference is being webcast live and can be accessed on the Internet at:
http://www.visualwebcaster.com/event.asp?id=4874. You may also access the Quest
Diagnostics website at: http://www.questdiagnostics.com . In addition, a replay
of the webcast will be available for 90 days following the conference.
Quest Diagnostics Incorporated is the nation's leading provider of diagnostic
testing, information and services, providing insights that enable physicians,
hospitals, managed care organizations and other healthcare professionals to make
decisions to improve health. The company offers the broadest access to
diagnostic laboratory services through its national network of laboratories and
patient service centers. Quest Diagnostics is the leading provider of esoteric
testing, including gene-based medical testing, and empowers healthcare
organizations and clinicians with state-of-the-art connectivity solutions that
improve practice management. Additional company information can be found on the
Internet at: http://www.questdiagnostics.com .
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking statements
involve risks and uncertainties that could cause the outcome to be materially
different. Certain of these risks and uncertainties are listed in the Quest
Diagnostics Incorporated 2001 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
CONTACT:
Media - Gary Samuels, +1-201-393-5700, or Investors - Laure
Park, +1-201-393-5030, both of Quest Diagnostics Incorporated
URL: http://www.questdiagnostics.com
Copyright (C) 2002 PR Newswire. All rights reserved.